UK-500001 is an orally active phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity; it inhibits TNF-α and IFN-γ release in human and rodent macrophage cell lines at nanomolar concentrations; it is used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma.